Ka ʻOihana Olakino

Notice: This is to inform providers of change in the way the Washington State Newborn Screening Program reports screening results. Beginning September 29th, 2025, results will be reported qualitatively instead of numerically. Analyte values will still be reported by our follow-up staff to the appropriate medical providers for babies needing referrals for diagnostic evaluation.

This change is designed to simplify result interpretation for newborn screening reporting. The approach will make it easier for providers to quickly identify results that require follow-up action while maintaining clarity for clinical decision-making.

Qualitative reporting will categorize results as:

• Screen Positive
• Screen Negative
• Borderline
• Indeterminate
• Specimen Unacceptable
• Test Not Done

Please see the example below:

Newborn Screening Results

Disorder	Result	Note
Congenital Adrenal Hyperplasia (CAH)	Screen Negative
Hemoglobinopathy	Screen Negative
Biotinidase	Screen Negative
Galactosemia	Screen Negative
Congenital Hypothyroidism (CH)	Screen Negative
Cystic Fibrosis (CF)	Screen Negative
AMINO ACID PROFILE	Screen Positive	See comment
ORGANIC ACID PROFILE	Screen Negative
FATTY ACID PROFILE	Screen Negative
Severe Combined Immunodeficiency (SCID)	Screen Positive	See comment
X-linked adrenoleukodystrophy (X-ALD)	Screen Negative
Glycogen Storage Disorder type II (POMPE)	Screen Negative
Mucopolysaccharidosis type I (MPS-I)	Screen Negative
Spinal Muscular Atrophy (SMA)	Screen Negative

What This Means for You:

• No changes to the screening process: The testing procedures and samples remain the same.
• Enhanced result interpretation: Results will be easier to understand and act upon.

---

If you have any questions or require further clarification, please feel free to contact us at (808) 733-9069 or [email protected]. We appreciate your continued partnership in ensuring the health and well-being of Hawaii’s newborns.